KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Common Equity (2020 - 2025)

Organon (OGN) has 6 years of Common Equity data on record, last reported at $752.0 million in Q4 2025.

  • For Q4 2025, Common Equity rose 59.32% year-over-year to $752.0 million; the TTM value through Dec 2025 reached $752.0 million, up 59.32%, while the annual FY2025 figure was $752.0 million, 59.32% up from the prior year.
  • Common Equity reached $752.0 million in Q4 2025 per OGN's latest filing, down from $906.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $4.7 billion in Q1 2021 and bottomed at -$1.9 billion in Q2 2021.
  • Average Common Equity over 5 years is -$127.2 million, with a median of -$312.5 million recorded in 2023.
  • Peak YoY movement for Common Equity: crashed 127.61% in 2021, then soared 1029.17% in 2025.
  • A 5-year view of Common Equity shows it stood at -$1.5 billion in 2021, then surged by 40.85% to -$892.0 million in 2022, then soared by 92.15% to -$70.0 million in 2023, then soared by 774.29% to $472.0 million in 2024, then skyrocketed by 59.32% to $752.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $752.0 million in Q4 2025, $906.0 million in Q3 2025, and $733.0 million in Q2 2025.